Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Senior V. P., Operations | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 11.2033 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 0.9556 · Balance 11.2033 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 11.1949 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 0.9556 · Balance 11.1949 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.5014 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 1.6351 · Balance 13.5014 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 14.774 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 1.9599 · Balance 14.774 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 12.2651 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 2.1927 · Balance 12.2651 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.0157 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 2.4831 · Balance 13.0157 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 9.4928 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 3.6735 · Balance 9.4928 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 8, 2026 20:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.6735 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385307 · ownership.xml · derivative · entry 7 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.4928 Underlying: Common Stock · 3.6735 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.4831 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385307 · ownership.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.0157 Underlying: Common Stock · 2.4831 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.1927 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385307 · ownership.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12.2651 Underlying: Common Stock · 2.1927 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.9599 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385307 · ownership.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.774 Underlying: Common Stock · 1.9599 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6351 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385307 · ownership.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.5014 Underlying: Common Stock · 1.6351 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9556 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385307 · ownership.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.1949 Underlying: Common Stock · 0.9556 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9556 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385307 · ownership.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.2033 Underlying: Common Stock · 0.9556 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.1523 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259990 · ownership.xml · derivative · entry 7 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.8193 Underlying: Common Stock · 3.1523 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.1306 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259990 · ownership.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.5326 Underlying: Common Stock · 2.1306 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.8813 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259990 · ownership.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.0724 Underlying: Common Stock · 1.8813 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6816 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259990 · ownership.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12.8141 Underlying: Common Stock · 1.6816 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.403 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259990 · ownership.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.8663 Underlying: Common Stock · 1.403 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.82 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259990 · ownership.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.2393 Underlying: Common Stock · 0.82 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.82 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259990 · ownership.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.2477 Underlying: Common Stock · 0.82 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 08, 2026 Filed May 11, 2026 21:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 2,928 | $107.00 | $313,286.92 |
DisclosureSEC source: 0001193125-26-217113 · ownership.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,749 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $105.32 to $107.46. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.667 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132143 · ownership.xml · derivative · entry 7 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.667 Underlying: Common Stock · 2.667 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.8027 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132143 · ownership.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.402 Underlying: Common Stock · 1.8027 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.5918 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132143 · ownership.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.1911 Underlying: Common Stock · 1.5918 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.4229 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132143 · ownership.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.1325 Underlying: Common Stock · 1.4229 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.187 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132143 · ownership.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.4633 Underlying: Common Stock · 1.187 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.6937 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132143 · ownership.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.4193 Underlying: Common Stock · 0.6937 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.6937 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132143 · ownership.xml · derivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.4277 Underlying: Common Stock · 0.6937 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:42 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,625 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001193125-26-106295 · ownership.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,353 Underlying: Common Stock · 2,625 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:42 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 2,625 | $108.50 | $284,812.50 |
DisclosureSEC source: 0001193125-26-106295 · ownership.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,677 Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:42 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,625 | $35.48 | $93,135.00 |
DisclosureSEC source: 0001193125-26-106295 · ownership.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 02:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 1,044 | $110.29 | $115,142.76 |
DisclosureSEC source: 0001193125-26-086289 · ownership.xml · nonDerivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,677 Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 02:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086289 · ownership.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.6 Underlying: Common Stock · 2 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 02:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 93 | $113.69 | $10,573.17 |
DisclosureSEC source: 0001193125-26-086289 · ownership.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,721 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on December 6, 2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 02:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086289 · ownership.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F2 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 02:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 1,051 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086289 · ownership.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,812 F1 · shares: These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,115 | $0.00 Strike: $48.60 | $0.00 |
DisclosureSEC source: 0001193125-26-010637 · ownership.xml · derivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,085 Underlying: Common Stock · 1,115 shares Expires 2028-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,229 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001193125-26-010637 · ownership.xml · derivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,690 Underlying: Common Stock · 1,229 shares Expires 2027-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1,115 | $48.60 | $54,189.00 |
DisclosureSEC source: 0001193125-26-010637 · ownership.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1,229 | $37.29 | $45,829.41 |
DisclosureSEC source: 0001193125-26-010637 · ownership.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319550 · ownership.xml · derivative · entry 9 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.7256 Underlying: Common Stock · 8 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319550 · ownership.xml · derivative · entry 8 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.734 Underlying: Common Stock · 8 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 90 | $84.00 | $7,560.00 |
DisclosureSEC source: 0001193125-25-319550 · ownership.xml · nonDerivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,417 F4 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319550 · ownership.xml · nonDerivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 90 | $84.00 | $7,560.00 |
DisclosureSEC source: 0001193125-25-319550 · ownership.xml · nonDerivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,499 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319550 · ownership.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 23:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319550 · ownership.xml · derivative · entry 7 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · balance_after: Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 23:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 90 | $83.36 | $7,502.40 |
DisclosureSEC source: 0001193125-25-319550 · ownership.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,581 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 23:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319550 · ownership.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 7,222 | $0.00 Strike: $83.66 | $0.00 |
DisclosureSEC source: 0001193125-25-316354 · ownership.xml · derivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,222 Underlying: Common Stock · 7,222 shares Expires 2032-12-10 F2 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 1,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-316354 · ownership.xml · nonDerivative · entry 1 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,660 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314624 · ownership.xml · derivative · entry 6 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.7096 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314624 · ownership.xml · derivative · entry 5 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.2763 Underlying: Common Stock · 4 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 92 | $82.93 | $7,629.56 |
DisclosureSEC source: 0001193125-25-314624 · ownership.xml · nonDerivative · entry 4 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,483 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/8/2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314624 · ownership.xml · nonDerivative · entry 3 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 77 | $82.93 | $6,385.61 |
DisclosureSEC source: 0001193125-25-314624 · ownership.xml · nonDerivative · entry 2 Kamke Trent G · CIK 0001365739 · Senior V. P., Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,570 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/8/2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.